NLGIA
TMO icon

Nippon Life Global Investors Americas’s Thermo Fisher Scientific TMO Stock Holding History

Nippon Life Global Investors Americas’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.33M Buy
14,610
+11,570
+381% +$5.55M 0.29% 56
2026
Q1 		$1.5M Sell
3,040
-200
-6% -$109K 0.07% 78
2025
Q4 		$1.88M Sell
3,240
-450
-12% -$254K 0.08% 77
2025
Q3 		$1.79M Sell
3,690
-780
-17% -$363K 0.08% 78
2025
Q2 		$1.81M Sell
4,470
-13,660
-75% -$5.71M 0.08% 76
2025
Q1 		$9.03M Sell
18,130
-53,090
-75% -$28.8M 0.44% 51
2024
Q4 		$37.1M Sell
71,220
-26,300
-27% -$14.5M 1.71% 18
2024
Q3 		$60.4M Buy
97,520
+14,890
+18% +$8.81M 2.59% 11
2024
Q2 		$45.7M Buy
82,630
+1,440
+2% +$825K 2.01% 16
2024
Q1 		$47.2M Buy
81,190
+10,580
+15% +$5.94M 2.2% 13
2023
Q4 		$37.5M Sell
70,610
-3,110
-4% -$1.51M 2.09% 13
2023
Q3 		$37.3M Buy
73,720
+13,340
+22% +$7.11M 2.3% 9
2023
Q2 		$31.5M Sell
60,380
-8,430
-12% -$4.55M 2.14% 10
2023
Q1 		$39.7M Buy
68,810
+26,930
+64% +$15.2M 2.54% 8
2022
Q4 		$23.1M Sell
41,880
-340
-0.8% -$180K 1.52% 23
2022
Q3 		$21.4M Buy
42,220
+14,440
+52% +$8.08M 1.51% 18
2022
Q2 		$15.1M Buy
27,780
+2,830
+11% +$1.56M 0.98% 33
2022
Q1 		$14.7M Sell
24,950
-1,480
-6% -$850K 0.79% 39
2021
Q4 		$17.6M Hold
26,430
– – 0.83% 33
2021
Q3 		$15.1M Buy
+26,430
New +$14.5M 0.79% 35
2017
Q3 		– Sell
-31,860
Closed -$5.56M – 151
2017
Q2 		$5.56M Sell
31,860
-10,180
-24% -$1.71M 0.48% 73
2017
Q1 		$6.46M Buy
42,040
+6,540
+18% +$1,000K 0.58% 60
2016
Q4 		$5.01M Buy
35,500
+2,510
+8% +$370K 0.46% 80
2016
Q3 		$5.25M Hold
32,990
– – 0.49% 74
2016
Q2 		$4.87M Buy
+32,990
New +$4.87M 0.47% 76
2013
Q3 		– Sell
-63,840
Closed -$5.4M – 143
2013
Q2 		$5.4M Buy
+63,840
New +$5.31M 0.6% 72

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nippon Life Global Investors Americas's TMO Position: Q2 2026 in Review

Nippon Life Global Investors Americas increased its Thermo Fisher Scientific (TMO) stake by 381% in Q2 2026, buying an estimated $5.55M and bringing the position to 14,610 shares worth $7.33M. The position accounts for 0.29% of the portfolio, ranked #56.

Nippon Life Global Investors Americas first reported a position in TMO in Q2 2013 and has held it in 26 quarters since. The position peaked at $60.4M in Q3 2024. 1,732 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nippon Life Global Investors Americas held 14,610 shares of Thermo Fisher Scientific worth $7.33M as of Q2 2026.
  • Nippon Life Global Investors Americas bought 11,570 Thermo Fisher Scientific shares in Q2 2026, an estimated $5.55M.
  • Thermo Fisher Scientific made up 0.29% of Nippon Life Global Investors Americas's portfolio in Q2 2026, its #56 holding.
  • Nippon Life Global Investors Americas first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 26 quarters since.
  • Nippon Life Global Investors Americas's Thermo Fisher Scientific position peaked at $60.4M in Q3 2024.
  • 1,732 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nippon Life Global Investors Americas's 13F filing for Q2 2026, filed 6 Aug 2026.